Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil in Prolonging Survival of HIV-Infected Individuals
NCT00001082Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 1996
- Primary completion
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adefovir dipivoxil in human immunodeficiency virus infection (HIV), cytomegalovirus infection (CMV), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 1996; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
human immunodeficiency virus infection (HIV)cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00001082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001082.